Related Experiment Video
Updated: Jun 24, 2026
10:37
Transcranial Direct Current Stimulation (tDCS) for Memory Enhancement
Published on: September 18, 2021
Therapeutic interventions in dementia 1: cognitive symptoms and function
Clare Taylor1, Karen Harrison Dening, Alan Duncan
1National Collaborating Centre for Mental Health.
Nursing Times
|April 1, 2009
Summary
This study focuses on therapeutic interventions for dementia, detailing methods to preserve patient function and independence. It also explores specific treatments targeting cognitive symptoms in individuals with dementia.
Area of Science:
- Gerontology
- Neurology
- Pharmacology
Background:
- Dementia significantly impacts patient function and independence.
- Cognitive symptoms are a hallmark of dementia, necessitating targeted interventions.
Purpose of the Study:
- To outline therapeutic interventions for dementia.
- To examine methods for maintaining patient function and independence.
- To explore interventions for cognitive symptoms in dementia.
Main Methods:
- Literature review of current therapeutic strategies.
- Analysis of interventions aimed at functional preservation.
- Examination of cognitive symptom management approaches.
Main Results:
- Established interventions can help maintain function and independence in dementia patients.
- Specific therapeutic approaches show promise in managing cognitive decline.
- A multi-faceted approach is often required for optimal outcomes.
Conclusions:
- Therapeutic interventions play a crucial role in dementia care.
- Maintaining function and independence is achievable through targeted strategies.
- Further research into novel interventions for cognitive symptoms is warranted.
Related Concept Videos
01:22Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
01:30Dementia
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
The progression of dementia is generally gradual.
01:22Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
01:30Cognitive Development During Adulthood
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function. They...